BIRC5 and breast carcinoma: CJ-1383 induced breast cancer cell apoptosis in a dose-dependent manner, while inhibition of tumor growth by the phosphopeptide mimetic PM-73G occurred without apoptosis or changes in the expression of cyclin D1 or survivin in xenograft models [201].